A groundbreaking prostate cancer screening trial, known as TRANSFORM, is set to commence in the UK with £42 million in funding from the government and Prostate Cancer UK. This trial aims to save thousands of men’s lives and spare their loved ones the tragedy of losing someone to this devastating disease.
[block_2]
Prostate cancer is the most common cancer among men in the UK, yet there is currently no national screening program in place. Often, symptoms do not manifest until the cancer has advanced, making it more difficult to treat. Tragically, approximately 12,000 men die from prostate cancer each year.
